DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Song JX, Ren JY, Chen H.
Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
J Cardiovasc Pharmacol 2011;
57: 213-222
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.